Virax Biolabs Group Ltd - VRAX

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$201K
QoQ value delta ($000)
+$190K (+1727.27%)
Implied price effect (QoQ)
-30.49%
Shares
Total shares
919,568
QoQ shares delta
+884,588 (+2528.84%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VRAX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 193 878,803 0.0%
Jump Financial, LLC 8 40,724 0.0%
OSAIC HOLDINGS, INC. 0 20 0.0%
Farther Finance Advisors, LLC 0 21 0.0%